BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34198635)

  • 1. Long-Term Follow-Up of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: Aims and Methodological Approach for Fondazione Italiana Linfomi Systematic Reviews.
    Gerardi C; Allocati E; Minoia C; Guarini A; Banzi R
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
    Oliva S; Puzzovivo A; Gerardi C; Allocati E; De Sanctis V; Minoia C; Skrypets T; Guarini A; Gini G
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.
    Nassi L; De Sanctis V; Loseto G; Gerardi C; Allocati E; Ciavarella S; Minoia C; Guarini A; Bari A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
    Franceschetti S; Annunziata MA; Agostinelli G; Gerardi C; Allocati E; Minoia C; Guarini A
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi.
    Minoia C; Gerardi C; Allocati E; Daniele A; De Sanctis V; Bari A; Guarini A
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
    Di Molfetta S; Daniele A; Gerardi C; Allocati E; Minoia C; Loseto G; Giorgino F; Guarini A; De Sanctis V
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male and Female Fertility: Prevention and Monitoring Hodgkin' Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi.
    Viviani S; Caccavari V; Gerardi C; Ramadan S; Allocati E; Minoia C; Guarini A; Di Russo A
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana.
    Minoia C; Viviani S; Silvestris E; Palini S; Parissone F; De Palma G; Fedina A; Cormio G; Guarini A; Gini G; Montano L; Merli F; Peccatori FA
    Front Oncol; 2023; 13():1252433. PubMed ID: 37766870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.
    Minoia C; Bari A; Nassi L; Banzi R; Gerardi C; Lenti V; Calabrese M; Spina M; Guarini A
    Tumori; 2021 Feb; 107(1):91-94. PubMed ID: 32116159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
    Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
    Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.
    Castellino A; Chiappella A; LaPlant BR; Pederson LD; Gaidano G; Macon WR; Inghirami G; Reeder CB; Tucci A; King RL; Congiu A; Foran JM; Pavone V; Rivera CE; Spina M; Ansell SM; Cavallo F; Molinari AL; Ciccone G; Habermann TM; Witzig TE; Vitolo U; Nowakowski GS
    Blood Cancer J; 2018 Nov; 8(11):108. PubMed ID: 30410035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.
    Filippi AR; Meregalli S; DI Russo A; Levis M; Ciammella P; Buglione M; Guerini AE; De Marco G; De Sanctis V; Vagge S; Ricardi U; Simontacchi G;
    Radiat Oncol; 2020 Mar; 15(1):62. PubMed ID: 32164700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Bernocco E; Monagheddu C; Evangelista A; Valeri F; Monaco F; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Visco C; Calabrese M; Limberti G; Levis A; Contino L; Ciccone G; Ladetto M
    Thromb Haemost; 2017 Apr; ():. PubMed ID: 28447710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
    Rigacci L; Puccini B; Zinzani PL; Biggi A; Castagnoli A; Merli F; Balzarotti M; Stelitano C; Spina M; Vitolo U; Stefoni V; Levis A; Gotti M; Rosaria S; Maria SP; Bosi A; Gallamini A
    Am J Hematol; 2015 Jun; 90(6):499-503. PubMed ID: 25720750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL).
    Gini G; Di Rocco A; Nassi L; Arcari A; Tisi MC; Loseto G; Olivieri A; Gentile M; Annibali O; Cabras MG; Chiappella A; Rusconi C; Ferreri AJM; Balzarotti M
    Front Oncol; 2021; 11():730194. PubMed ID: 34804924
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
    Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
    Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
    Bari A; Gerardi C; Allocati E; Puzzovivo A; De Sanctis V; Tucci A; Balzarotti M; Franceschetti S; Merli F; Guarini A; Gini G; Minoia C
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
    Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
    Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews.
    Lindenmeyer LP; Hegele V; Caregnato JP; Wüst D; Grazziotin L; Stoll P
    Ann Hematol; 2013 Nov; 92(11):1451-9. PubMed ID: 23748882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.